查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612570

生物标记测试服务市场：按服务、技术、疾病领域、应用、最终用户划分 - 全球预测 2025-2030

Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物标记测试服务市场2023年估值为9.649亿美元，预计到2024年将达到10.3196亿美元，复合年增长率为7.34%，预计到2030年将达到15.8504亿美元。

生物标记测试服务包括利用生物标记检测、评估和监测健康状况的诊断过程，特别是在肿瘤学、神经病学、心臟病学和感染疾病方面。这种测试对于精准医学至关重要，可以根据个人的基因谱量身定制治疗方案，通常会带来更好的结果。生物标记测试的应用范围包括早期疾病诊断、治疗指南、预后和监测治疗反应。市场的主要最终用户是医院、诊断实验室、研究机构和製药公司。关键的成长要素包括慢性病的增加、基因组学和蛋白​​质组学的进步以及对个人化医疗的日益关注。技术进步，特别是次世代定序和数数位化诊断，为扩大和改进生物标记的应用提供了机会。公司可以透过投资与基因组研究机构建立合作伙伴关係和共同开发来开发联合品牌诊断解决方案来获得资金。

主要市场统计
基准年[2023] 9.649 亿美元
预计年份 [2024] 1,031,960,000 美元
预测年份 [2030] 15.8504亿美元
复合年增长率（%） 7.34%

然而，该市场面临局限性，例如与生物标记发现和检验相关的高成本、多分析物检测的监管挑战以及资料管理问题。各种生物标记的标准化和整合以进行综合分析也面临挑战。创新应着重于透过自动化整合平台降低成本、加强资料整合策略以及开发强大且可扩展的检验方法。另一个有前景的领域是人工智慧的集成，以简化生物标誌物的发现和资料解释过程。这个市场充满活力，其特点是技术快速进步和透过附加价值服务实现竞争差异化。该领域的成功需要采取策略方法来促进合作研究、投资先进技术并遵守法规环境。掌握行业趋势并优先考虑以客户为中心的创新对于在不断变化的环境中抓住市场机会并推动公司发展至关重要。

市场动态：针对快速发展的生物标记测试服务市场揭示的关键市场洞察

供需的动态交互作用正在改变生物标记测试服务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 抗癌药物开发的增加和对高性能生物标记的需求
    • 政府对生物标誌研究的措施和投资
    • 加强对生物标誌物检测的财政支持
  • 市场限制因素
    • 生物标记测试既耗时又昂贵
  • 市场机会
    • 使用人工智慧和机器学习的生物标记测试工具和设备的进步
    • 提供生物标记测试和分析服务的 CDMO 的出现
  • 市场挑战
    • 由于样本采集和缺乏真实性而造成测试障碍

波特五力：驾驭生物标记测试服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物标记测试服务市场的外部影响

外部宏观环境因素在塑造生物标记测试服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物标记检测服务市场的竞争状况

生物标记测试服务市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生物标记测试服务市场供应商的绩效评估

FPNV 定位矩阵是评估生物标记测试服务市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划生物标记测试服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物标誌物测试服务市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症药物开发的增加和对高性能生物标记的需求
      • 政府对生物标誌研究的措施和投资
      • 改善生物标誌物测试的财务支援的可用性
    • 抑制因素
      • 生物标记测试是一个缓慢且昂贵的过程
    • 机会
      • 使用人工智慧和机器学习的生物标记测试工具和设备的进步
      • 提供生物标记测试和分析服务的新兴 CDMO
    • 任务
      • 由于样本收集和缺乏可靠性而造成测试障碍
  • 市场区隔分析
    • 技术：不断进步，提升聚合酵素链锁反应技术的通用性、速度和扩增能力
    • 最终用户：生物标记测试服务在製药和生物技术公司治疗性介入的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物标记测试服务市场：依服务分类

  • 生物标记测定的开发和检验
  • 流式细胞技术

第七章生物标记检测服务市场技术

  • 酵素免疫分析法
  • 质谱分析
  • 次世代定序
  • 聚合酵素链锁反应

第八章依疾病领域分類的生物标记检测服务市场

  • 自体免疫疾病
  • 癌症
  • 心血管疾病
  • 神经系统疾病

第九章生物标记测试服务市场：依应用分类

  • 药物作用机制
  • 动态
  • 预测性临床研究
  • 预后

第 10 章 生物标记测试服务市场：依最终用户分类

  • 合约调查机构
  • 製药和生物技术公司
  • 调查机构

第十一章美洲生物标记检测服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太生物标记检测服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲/中东/非洲生物标记检测服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Mayo Clinic Laboratories 和 Progentec 合作为自体免疫疾病患者提供先进的生物标记检测服务
    • 新的前列腺癌生物标记测试登陆美国市场
    • Quanterix 推出 LucentAD 生物标记血液检测，帮助医生诊断阿兹海默症患者
  • 战略分析和建议

公司名单

  • Abcam PLC by Danaher Corporation
  • Agilent Technologies, Inc.
  • Avid Bioservices, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • BiomarkerBay BV
  • Bristol Myers Squibb
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Icon PLC
  • Intertek Group PLC
  • IQVIA
  • JSR Life Sciences, LLC
  • KCAS Group
  • Laboratory Corporation of America Holdings
  • LGC Group
  • Merck KGaA
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories
  • Parexel International Corporation
  • PerkinElmer Inc.
  • Randox Laboratories
  • SGS SA
  • Shuwen Biotech Co., Ltd.
  • Syneos Health
  • Thermo Fisher Scientific, Inc.
  • WuXi Biologics Inc.
Product Code: MRR-B16853779DF0

The Biomarker Testing Services Market was valued at USD 964.90 million in 2023, expected to reach USD 1,031.96 million in 2024, and is projected to grow at a CAGR of 7.34%, to USD 1,585.04 million by 2030.

Biomarker testing services encompass diagnostic processes that utilize biomarkers to detect, evaluate, and monitor health conditions, particularly in oncology, neurology, cardiology, and infectious diseases. This testing is essential for precision medicine, wherein treatments can be tailored to the individual's genetic profile, often leading to better outcomes. The application of biomarker testing spans early disease diagnosis, therapeutic guidance, prognosis, and monitoring treatment response. Within the market, the primary end-users are hospitals, diagnostic laboratories, research organizations, and pharmaceutical companies. Key growth factors include the rise in chronic diseases, advancements in genomics and proteomics, and an increased focus on personalized medicine. Technological advancements, particularly in next-generation sequencing and digitalized diagnostics, present opportunities to expand and refine biomarker applications. Companies can capitalize by investing in partnerships and collaborations with genomic research entities to develop co-branded diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 964.90 million
Estimated Year [2024] USD 1,031.96 million
Forecast Year [2030] USD 1,585.04 million
CAGR (%) 7.34%

However, the market faces limitations such as high costs associated with biomarker discovery and validation, regulatory challenges around multi-analyte assays, and data management issues. Challenges also arise in standardization and the integration of diverse biomarker types for comprehensive analysis. Innovations should focus on reducing costs via automated and integrated platforms, enhancing data integration strategies, and developing robust, scalable validation methodologies. Another promising area is the integration of AI to streamline biomarker discovery and data interpretation processes. The market is highly dynamic, characterized by rapid technological advancements and competitive differentiation through value-added services. Success in this field requires a strategic approach towards fostering collaborations, investing in advanced technologies, and complying with regulatory environments. Staying updated with industry trends and prioritizing customer-centric innovations will be crucial to capturing market opportunities and driving company growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomarker Testing Services Market

The Biomarker Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cancer drug development and need for high-performing biomarkers
    • Government initiatives and investments for biomarker research
    • Improved availability of financial coverage for biomarker testing
  • Market Restraints
    • Time-consuming and expensive process of biomarker testing
  • Market Opportunities
    • Advancements in biomarker testing tools & equipment with AI & ML
    • Emerging CDMOs offering biomarker testing and analysis services
  • Market Challenges
    • Barriers in testing due to lack of sample collection and authenticity

Porter's Five Forces: A Strategic Tool for Navigating the Biomarker Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomarker Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomarker Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomarker Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomarker Testing Services Market

A detailed market share analysis in the Biomarker Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomarker Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomarker Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomarker Testing Services Market

A strategic analysis of the Biomarker Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Biomarker Assay Development & Validation and Flow Cytometry.
  • Based on Techonology, market is studied across Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Disease Area, market is studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, and Neurological Disorders.
  • Based on Application, market is studied across Drug Mechanism of Action, Pharmacodynamic, Predictive Clinical Studies, and Prognostic.
  • Based on End-User, market is studied across Contract Research Oraganizations, Pharmaceutical & biotechnology companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
      • 5.1.1.2. Government initiatives and investments for biomarker research
      • 5.1.1.3. Improved availability of financial coverage for biomarker testing
    • 5.1.2. Restraints
      • 5.1.2.1. Time-consuming and expensive process of biomarker testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
      • 5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
    • 5.1.4. Challenges
      • 5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • 5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomarker Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Biomarker Assay Development & Validation
  • 6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Mass Spectrometry
  • 7.4. Next-Generation Sequencing
  • 7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Cardiovascular Diseases
  • 8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Mechanism of Action
  • 9.3. Pharmacodynamic
  • 9.4. Predictive Clinical Studies
  • 9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Oraganizations
  • 10.3. Pharmaceutical & biotechnology companies
  • 10.4. Research Institutes

11. Americas Biomarker Testing Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
    • 14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
    • 14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Agilent Technologies, Inc.
  • 3. Avid Bioservices, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioAgilytix Labs
  • 6. BiomarkerBay B. V.
  • 7. Bristol Myers Squibb
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Icon PLC
  • 11. Intertek Group PLC
  • 12. IQVIA
  • 13. JSR Life Sciences, LLC
  • 14. KCAS Group
  • 15. Laboratory Corporation of America Holdings
  • 16. LGC Group
  • 17. Merck KGaA
  • 18. Myriad Genetics, Inc.
  • 19. NeoGenomics Laboratories
  • 20. Parexel International Corporation
  • 21. PerkinElmer Inc.
  • 22. Randox Laboratories
  • 23. SGS S.A.
  • 24. Shuwen Biotech Co., Ltd.
  • 25. Syneos Health
  • 26. Thermo Fisher Scientific, Inc.
  • 27. WuXi Biologics Inc.

LIST OF FIGURES

  • FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023